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ABSTRACT It has been claimed recently that it may be possible to predict the rate of de novomutation of each
site in the human genome with a high degree of accuracy [Michaelson et al. (2012), Cell 151: 143121442]. We
show that this claim is unwarranted. By considering the correlation between the rate of de novo mutation and
the predictions from the model of Michaelson et al., we show there could be substantial unexplained variance in
the mutation rate. We investigate whether the model of Michaelson et al. captures variation at the single
nucleotide level that is not due to simple context. We show that the model captures a substantial fraction of








It has been known for some time, from comparative studies, that the
mutation rate varies at a number of different scales along the human
genome, from variation between individual nucleotides, to differences
between whole chromosomes (Hodgkinson and Eyre-Walker 2011).
Much of this variation has remained unexplained (Hodgkinson and
Eyre-Walker 2011). However, Michaelson et al. (2012) recently have
claimed that the rate of mutation at each site is highly predictable.
They use principle component logistic regression ﬁtted to a dataset of
653 de novo mutations (DNMs) to estimate a model from which they
can predict the mutability index (MI), a measure of the mutation rate,
of each site in the human genome. To assess the ﬁt of the model, they
count the number of sites in the genome with a particular MI (n) and
the number of DNMs at those sites (d). They therefore have a pre-
diction of the mutation rate from their model, the MI, and the ob-
served rate of mutation, z=d/n. They ﬁnd a very strong correlation
between the logarithm of z and MI and infer that
MI was highly predictive of site-speciﬁc (1 bp resolution)
mutation rates . . . and could explain 90% of the variability in
mutation rates at sites across the genome. . ...We conclude that
our statistical model of mutability can explain a majority of the
variance in site-speciﬁc mutation rates.
However, for each MI value they have thousands to millions of sites.
As a consequence, any variation that their model does not explain will
be averaged out when they consider the observed number of mutations.
This can be illustrated as follows. Consider sites with an MI such that
their mutation rate is 1028, approximately the mean mutation rate in
humans (1000 Genomes Project Consortium 2010; Awadalla et al. 2010;
Conrad et al. 2011). If the model of Michaelson et al. (2012) explains all
the variation in the mutation rate then all sites with this MI will have
a mutation rate of 1028. However, if there is unexplained variance, the
mutation rate of each site will deviate from this value. Let us assume that
equal numbers of sites with this MI actually have mutation rates of 0.1 ·
1028 and 1.9 · 1028; the mean mutation rate for sites with this MI is
still 1028. It is clear that if we only sample a few sites, then the observed
mean mutation rate often will deviate substantially from the average
value of 1028, and the correlation between the log of the observed
number of DNMs and the MI will be correspondingly weak if we have
similar levels of variation at sites with other MI values. However, as we
sample more and more sites, the mean value will approach the expected
value of 1028 and the correlation between the log of the number of
DNMs per site and MI will become better [assuming that the model of
Michaelson et al. (2012) explains at least some of the variance]. Because
there are typically thousands if not millions of sites for each MI value,
any unexplained variance will be averaged away.
Here we examine how much variation there could be that is
unexplained by the model of Michaelson et al. (2012). We also test
whether their model explains a source of variation in the mutation
rate that is both strong and likely to be difﬁcult to explain – cryptic
variation in the mutation rate. This is variation that exists at the single
nucleotide level but which appears to be independent of the context of
the adjacent nucleotides. Cryptic variation was ﬁrst discovered in
mammalian nuclear DNA by noting that there is an excess of
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single-nucleotide polymorphisms (SNPs) that occur at the same site in
humans and chimpanzees, even when the inﬂuence of the adjacent
nucleotides on the mutation rate is taken into account (Hodgkinson
et al. 2009; see also Lefﬂer et al. 2013). A similar excess has been noted
for single-nucleotide substitutions in pairs of independent primate
species (Johnson and Hellmann 2011). This excess of SNPs does
not appear to be due to ancestral polymorphism, sequence assembly
errors, or balanced polymorphism because the allele frequencies at
sites with SNPs in both humans and chimpanzees are no different
to other polymorphic sites (Johnson and Hellmann 2011; see also
additional discussion in Johnson and Hellmann 2011 and at http://
www.plosbiology.org/annotation/listThread.action?root=21243). Esti-
mates suggest there might be as much variation in the mutation rate
that is not associated with context as there is associated with context
(Hodgkinson et al. 2009). However, predicting whether a site is cryp-
tically hyper- or hypomutable is likely to be difﬁcult, because the
increase or decrease in the mutation rate is extremely precise—it
affects one nucleotide and not the adjoining sites—and it does not
depend on the adjacent nucleotides.
MATERIALS AND METHODS
Data
We downloaded details of DNMs from the supplementary informa-
tion of several publications (Conrad et al. 2011; Iossifov et al. 2012;
Kong et al. 2012; Michaelson et al. 2012; Neale et al. 2012; O’Roak
et al. 2011; Sanders et al. 2012). If necessary these were lifted over to
hg18, the human genome assembly used by Michaelson et al. (2012).
Simulating data
We simulated data under the model of Michaelson et al. (2012) as
follows. First, for a dataset of DNMs we regressed, using weighted re-
gression, the log of the observed number of DNMs per site, z, against
MI, to yield the relationship between the mutation rate and MI under
the Michaelson model. Because there are a limited number of DNMs for
some MI values, we binned the MI values into groups of 10 and re-
moved those bins that had 5 or fewer DNMs. Using the regression
equation, and the number of sites, we predicted the expected number
of mutations at sites with an MI of x, Z(x). To generate data under the
assumption that the Michaelson model explains all the variance in the
mutation rate, we sampled from a Poisson distribution with expected
values Z(x). To investigate the effect of variance unexplained by the
Michaelson model, we added an additional step to the simulation. Hav-
ing used the regression model (of log(DNMs per site) vs. MI) to predict
the expected number of mutations for a site with an MI of x, Z(x), we
multiplied this by a random variate drawn from a lognormal distribu-
tion with variance = ϒ/n, where n is the number of sites and ϒ is the
variance in the mutation rate at each site unexplained by the Michaelson
model. This yielded the expected number of mutations for sites with an
MI of x; to generate the observed number we sampled from a Poisson
distribution. The logic is as follows; the mean mutation rate for sites with
an MI of x is Z(x), but the rate of a particular site is Z(x)a where a is
a random variate that is lognormally distributed. Because the mean of n
lognormally distributed variates, each with a variance ϒ, is itself approx-
imately lognormal with a variance equal to ϒ/n (Beaulieu et al. 1995;
Fenton 1960), we can simulate the effect of unexplained variation among
sites with an MI of x by multiplying the expected mutation rate by
a random lognormal variate with variance ϒ/n. We generated 1000
simulated datasets and calculated the correlation between MI and the
log of the simulated number of mutations per site. Occasionally the
simulation would generate no DNMs for an MI value; we removed
these datasets. We then compared the correlation between the log of
the observed number of DNMs and MI against the correlation between
the log of the simulated number of DNMs and MI. To take into account
the uncertainty in the relationship between the log of the observed
mutation rate and MI, we bootstrapped the data before performing
the regression by resampling the data points from the regression.
Coincident SNP analysis
We investigated the difference in the mutation rate between sites with
and without a coincident SNP (a site with a SNP in both humans and
chimpanzees) as follows. We assume that the distribution of mutation
rates is a gamma distribution arbitrarily scaled such that the mean of
the distribution is one; it is therefore characterized solely by its shape
parameter. We also assume that hypermutable sites destroy them-
selves when they mutate. This assumption makes little difference to
the non-CpG analysis but reduces the level of variation needed to
explain the coincident SNPs in the CpG analysis. Hodgkinson et al.
(2009) have shown that under this model the probability of observing
a coincident SNP at a site is
P ¼ uhuc
Z
DðgÞe2vgg2 þ 12 e22vgdg (1)
where uh and uc are the density of SNPs in the two species being
considered, v is the average divergence between the species and D(g)
is the distribution of the rates. Therefore the average mutation rate
of sites with coincident SNPs, relative to the average mutation rate
(arbitrarily set to one) is
Q ¼
R ðDðgÞe2vgg2 þ ð12 e22vgÞÞgdgR ðDðgÞe2vgg2 þ ð12 e22vgÞÞdg (2)
In our calculations, we assume that the divergence at non-CpG sites
between human and chimpanzee sites is 0.0092 (Chimpanzee-
Sequencing-and-Analysis-Consortium 2005) with the divergence at
CpG sites 10x higher at 0.092 (Chimpanzee-Sequencing-and-Analysis-
Consortium 2005; Hwang and Green 2004).
We used the coincident SNPs found in humans and chimpanzees
discovered by Lefﬂer et al. (2013). We did not exclude coincident
SNPs that they had inferred to be subject to balancing selection be-
cause there were ,300 of these of a total of 34,000 coincident SNPs
RESULTS AND DISCUSSION
Michaelson et al. (2012) assessed the ﬁt of their model by comparing the
mutation rate predicted by their model to the observed number of DNMs.
In doing so, they averaged the mutation rate across thousands if not
millions of sites, potentially hiding unexplained variance in the mutation
rate. To investigate how much unexplained variance there might be,
we simulated data under their model (henceforth referred to as the
Michaelson model) with and without additional variance. In the sim-
ulation we estimated the relationship between MI (i.e., the Michaelson
model) and the rate of mutation using sets of DNMs. We then used
this relationship to predict the expected number of mutations at a site
and then simulated data based on these expectations with and without
additional variation in the mutation rate (details in the sectionMaterials
and Methods). We performed the analysis for three sets of DNMs:
(i) the 652 DNMs reported by Michaelson et al. (2012) and used to
build the model upon which the MI values are based (referred to as
the Michaelson data), (ii) 1380 DNMs reported by various other studies
(Conrad et al. 2011; Iossifov et al. 2012; Neale et al. 2012; O’Roak et al.
2011; Sanders et al. 2012) (Other data), and (iii) 4933 DNMs reported
by Kong et al. (2012) (Kong data; note that only DNMs with an MI
value were included).
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As previously shown by Michaelson et al. (2012), the correlation
between the log of the number of DNMs per site and the MI value is
very strong for the Michaelson data (r = 0.98, P , 0.001; Figure 1A);
this ﬁnding is perhaps not surprising, given that these were the data
used to construct the Michaelson model and the model is relatively
parameter rich. However, as Michaelson et al. (2012) showed, their
model also ﬁts the data from other studies well (r = 0.97, P , 0.001;
Figure 1B), although there is a clear nonlinearity in the relationship (a
quadratic term in a nonlinear regression is signiﬁcant P = 0.010).
However, the ﬁt of the Michaelson model to the Kong data, which
Michaelson et al. (2012) did not study, is relatively poor (r = 0.94,
P , 0.001; Figure 1C). The problem would seem to lie with the Kong
data, since the model ﬁts the other two datasets well. The slope of the
regression line from the Kong data [0.0047 (0.0006)] is signiﬁcantly less
than that observed for the Michaelson et al. (2012) [0.010 (0.0007)] and
Other datasets [0.0084 (0.0007)], suggesting that there has been sys-
tematic underreporting of DNMs from the more mutable areas of the
genome in the Kong et al. (2012) dataset (or alternatively, that there are
large numbers of false positives in the less mutable parts).
If we assume that the Michaelson model explains all the variation
in the mutation rate, we ﬁnd that simulated datasets have similar
levels of correlation between the log of the number of DNMs per site
and MI to that observed in the real data for the Michaelson and other
datasets, i.e., any variance not explained by the Michaelson model can
be attributed to sampling error due to the fact that there are limited
number of DNMs (Table 1). All the simulated correlations are stron-
ger than the observed correlation in the Kong data, but this is prob-
ably because the Michaelson model ﬁts these data poorly.
However, despite the good ﬁt between model and data for two
of the datasets, we ﬁnd that there could be very substantial levels of
unexplained variance and the correlations would remain almost
unaffected (Table 1). Only when the variance associated with the
unexplained variance approaches 105 do we see the correlations being
affected and approaching the values seen in the real data. This level of
variance dwarfs that explained by the Michaelson model; the coefﬁ-
cient of variation in the mutation rate explained by the Michaelson
model is 1.10, the coefﬁcient of variation for the unexplained variation
is 300 if the variance is 105. This analysis therefore shows that there
could be a substantial amount of unexplained variance that would
never be detected, assessing model ﬁt as Michaelson et al. (2012) have
done. However, it does not show that this unexplained variance exists.
Assessing model ﬁt is not easy with these datasets; there are very few
DNMs spread across millions of sites. We therefore sought to test one
component of mutation rate variation that is both substantial and likely to
be difﬁcult to predict, the so-called cryptic variation in the mutation rate
(Hodgkinson et al. 2009; Johnson and Hellmann 2011). This is variation
at the single-nucleotide level that is independent of adjacent nucleotides.
To investigate whether the model of Michaelson et al. (2012)
captures cryptic variation in the mutation rate we proceeded as fol-
lows. Sites with SNPs in both humans and chimpanzees are inferred to
have greater mutation rates than sites without coincident SNPs. Using
some simple theory, we can estimate how much more mutable these
sites need to be on average to yield the observed excess of coincident
SNPs, and we can then compare this with the difference in mutation
rate predicted by the Michaelson model for sites with and without
coincident SNPs. If the Michaelson model captures cryptic variation
in the mutation rate then it should correctly predict the level of
variation needed to explain the observed excess of coincident SNPs.
Although coincident SNPs and DNMs are measuring variation in
the mutation rate over very different time scales, it is expected that any
source of variation identiﬁable through coincident SNPs should also
be present in DNMs. In fact if variation in the mutation rate evolves
through time, we would expect the variation associated with co-
incident SNPs to be less than that present in DNMs.
Lefﬂer et al. (2013) have shown, using a carefully curated dataset of
human and chimpanzee SNPs, that there is a 16% excess of coincident
SNPs at CpG sites (95% conﬁdence intervals of 14% and 17%) and
a 83% (80%, 86%) excess at non-CpG sites between human and
chimpanzee, when correcting for the nucleotides at the adjacent sites.
Assuming that rates are gamma distributed across sites, we estimate,
using the theory set out by Hodgkinson et al. (2009), that sites with
coincident SNPs are 1.40-fold (95% conﬁdence intervals of 1.35, 1.43)
and 2.71-fold (2.65, 2.77) more mutable on average than the genomic
Figure 1 The log of the number of de novo mutations (DNMs) per site
vs. the mutability index (MI). The mutability index for the (A) Michael-
son, (B) Other, and (C) Kong datasets.
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average for CpG and non-CpG sites respectively. How do these values
compare to those under the Michaelson model? Under the Michaelson
model, we ﬁnd that sites with coincident SNPs have signiﬁcantly greater
MI values at both CpG (mean MI for coincident sites = 91.6, non-
coincident sites = 81.4; P, 0.001) and non-CpG sites (coincident sites =
27.77, noncoincident sites = 216.0, P , 0.001). However, the differ-
ences in MI are small and equate to minor differences in the mutation
rate predicted using the regression model from the data of Michaelson
et al. (2012); coincident SNPs are predicted to be 1.21-fold (1.21, 1.21)
more mutable at CpG and 1.17-fold (1.17, 1.17) more mutable at non-
CpG sites. Thus, our analysis suggests that the Michaelson model may
capture a substantial fraction, although by no means all, of the variation
at CpG sites; the level of variation required to explain the excess of
coincident SNPs at CpG sites is such that we would expect sites with
coincident SNPs to be 1.40-fold (1.35, 1.43) more mutable than non-
coincident sites and the Michaelson model predicts them to 1.21-fold
(1.21, 1.21) more mutable; these estimates are signiﬁcantly different (P,
0.001). However, the Michaelson model seems to fail to capture most of
the variation at non-CpG sites; sites with coincident SNPs are expected
to be 2.71-fold (2.65, 2.77) more mutable than noncoincident sites, but
the Michaelson model predicts them to be only 1.17-fold (1.17, 1.17)
more mutable. These estimates are signiﬁcantly different (P , 0.001).
Although the Michaelson model appears to explain a substantial
fraction of the variation at CpG sites this might be deceptive because
the level of cryptic variation may have been underestimated by
analyzing coincident SNPs. Cryptic variation is, by its deﬁnition,
variation that does not depend upon the context of the immediately
adjacent nucleotides. However, it is possible, in fact likely, that cryptic
variation depends upon context in some manner, may be through
a dispersed context (for example, if the second nucleotide upstream is
an A and ﬁfth nucleotide downstream is a C, etc). If this is the case
then as the context evolves so the mutation rate at the focal site will
change. This will lead to a reduction in the correlation in the mutation
rate between sites in humans and chimpanzees and hence to a lower
level of variation inferred from coincident SNPs. However, one might
argue that the level of variation is overestimated by a consideration of
coincident SNPs, because SNPs can be subject to natural selection,
which will tend to increase the number of coincident SNPs by
excluding SNPs from certain parts of the genome. This seems
unlikely because less than 10% of the human genome is inferred to
be subject to selection (Eory et al. 2010; Lunter et al. 2006).
Currently we do not have a robust estimate of how much of the
total variance in the mutation rate is contributed by cryptic variation.
Initial rough estimates suggest that there is approximately as much
variation associated with cryptic variation as there is with simple
context (i.e., CpG type effects) (Hodgkinson et al. 2009). Because
variation at the single-nucleotide level appears to contribute the most
to variation in the mutation rate (Hodgkinson and Eyre-Walker 2011)
it would seem that the Michaelson model is missing a major compo-
nent of the variation, particularly at non-CpG sites.
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n Table 1 The proportion of simulated datasets with a greater
correlation between the log of the number of DNMs per site and
MI than observed in the actual data
v Michaelson et al. (2012) Other Kong et al. (2012)
0 0.81 0.78 1.0
1000 0.82 0.79 1.0
10,000 0.81 0.76 1.0
100,000 0.76 0.72 0.99
500,000 0.59 0.49 0.92
1,000,000 0.43 0.35 0.70
2,000,000 0.25 0.17 0.36
3,000,000 0.16 0.088 0.20
4,000,000 0.10 0.069 0.13
5,000,000 0.076 0.032 0.084
DNMs, de novo mutations; MI, mutability index.
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